Formation Biologics
Latest round
- Series C
Last raised
- Jul 2019
Total raised
- $1.5M
Investors
- 5
About Formation Biologics
Formation Biologics Inc.Formation Biologics Inc. was founded in 2011 in Austin, US, specializing in biotechnology solutions. The company underwent a significant change when it was acquired by Bristol-Myers Squibb Company in September 2020. The founder's history and other details about the company's previous operations are not available.Forbius specializes in developing innovative biotechnology solutions aimed at enhancing health outcomes. The company’s core product offerings include a range of biopharmaceuticals designed to address various medical conditions through therapeutic mechanisms. These products are targeted at improving patient health in sectors such as oncology and immunology, focusing on precision medicine for tailored treatments. Forbius serves a diverse client base, including hospitals, specialty clinics, and research institutions across North America and Europe, reflecting its commitment to addressing unmet medical needs in these regions.Forbius generates revenue primarily through partnerships and direct sales of its biopharmaceutical products. The company engages in B2B transactions, collaborating with healthcare providers and institutions to distribute its offerings. Revenue streams are supported by strategic partnerships with pharmaceutical companies, involving licensing agreements or co-development arrangements. Pricing plans are structured to reflect the value and efficacy of their flagship products in the market.Since the acquisition by Bristol-Myers Squibb Company in September 2020, Formation Biologics Inc. has been focusing on integrating its innovative solutions within a larger portfolio. Specific future products and their release dates have not been disclosed, but the company is expected to leverage its capabilities in oncology and immunology. The strategy aims to increase market presence in North America and Europe while further enhancing its product offerings.
Who invested in Formation Biologics
5 investors across 3 rounds
See all investors in Formation Biologics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Formation Biologics
Who invested in Formation Biologics?
Formation Biologics has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Formation Biologics raised?
Formation Biologics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Formation Biologics last raise money?
Formation Biologics's most recent round on record is a Series C, in Jul 2019.
What does Formation Biologics do?
Formation Biologics is a pharmaceuticals company.
Where is Formation Biologics headquartered?
Formation Biologics is headquartered in Austin, US.
Which VCs invest in companies like Formation Biologics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Formation Biologics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Formation Biologics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.